Occult Metastasis in Laryngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

被引:27
作者
Sharbel, Daniel D. [1 ]
Abkemeier, Mary [2 ]
Groves, Michael W. [1 ]
Albergotti, William G. [1 ]
Byrd, J. Kenneth [1 ]
Reyes-Gelves, Camilo [1 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Otolaryngol Head & Neck Surg, 1120 15th St,BP 4109, Augusta, GA 30912 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
关键词
occult metastasis; laryngeal cancer; supraglottic cancer; elective neck dissection; squamous cell carcinoma; CLINICALLY NEGATIVE NECK; LYMPH-NODE METASTASIS; N0; NECK; PHARYNGOCUTANEOUS FISTULA; LEVEL-IV; DISSECTION; MANAGEMENT; CANCER; HEAD; EFFICACY;
D O I
10.1177/0003489420937744
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: The incidence of occult metastasis (OM) in laryngeal squamous cell carcinoma (SCC) is still widely debated. In this systematic review, we aim to determine the rate of OM in laryngeal SCC, its impact on recurrence, and the role of elective neck dissection (END) in the management of the clinically negative neck. Methods: A systematic review of the English-language literature in Web of Science, PubMed, MEDLINE, and Cochrane Library databases on occult metastasis in laryngeal SCC from 1977 to 2018 was conducted. Studies evaluating occult metastasis (OM) in patients with laryngeal SCC with clinically negative necks undergoing surgery were included. Studies evaluating other head and neck subsites, clinically node positive, and salvage patients were excluded. Results: Twenty-one articles with a total of 5630 patients were included. The overall rate of OM was 20.5% and was 23% and 12.2% in supraglottic and glottic tumors, respectively. The OM rate in T1-T2 tumors was 13% and 25% in T3-T4 tumors. T3-T4 tumors had significantly greater odds of developing OM compared to T1-T2 tumors (Odds Ratio [OR] = 2.61, 95% Confidence Interval [CI] = 1.92-3.55,P < .00001). Patients with OM were more likely to develop distant metastasis (OR = 5.65, 95% CI = 3.36-9.51,P < .00001). Conclusions: Patients with advanced T-stage laryngeal SCC should undergo elective neck treatment. More aggressive treatment for patients with history of OM should be considered due to the risk of subsequent regional and distant metastasis.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 52 条
[1]   Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer [J].
Alpert, TE ;
Morbidini-Gaffney, S ;
Chung, CT ;
Bogart, JA ;
Hahn, SS ;
Hsu, J ;
Kellman, RM .
CANCER JOURNAL, 2004, 10 (06) :335-338
[2]   Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) [J].
Bernier, J ;
Cooper, JS ;
Pajak, TF ;
van Glabbeke, M ;
Bourhis, J ;
Forastiere, A ;
Ozsahin, EM ;
Jacobs, JR ;
Jassem, J ;
Ang, KK ;
Lefèbvre, JL .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (10) :843-850
[3]  
BOCCA E, 1984, LARYNGOSCOPE, V94, P1086
[4]  
Brentani RR, 1999, HEAD NECK-J SCI SPEC, V21, P694
[5]  
Busoni M, 2015, ACTA OTORHINOLARYNGO, V35, P400, DOI 10.14639/0392-100X-626
[6]   RATIONALE FOR ELECTIVE MODIFIED NECK DISSECTION [J].
BYERS, RM ;
WOLF, PF ;
BALLANTYNE, AJ .
HEAD & NECK SURGERY, 1988, 10 (03) :160-167
[7]   Is routine bilateral neck dissection absolutely necessary in the management of N0 neck in patients with supraglottic carcinoma? [J].
Cagh, S. ;
Yuece, I. ;
Yigitbasi, O. G. ;
Gueney, E. .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (12) :1453-1457
[8]   Is routine inclusion of level IV necessary in neck dissection for clinically NO supraglottic carcinoma? [J].
Cagli, Sedat ;
Yuece, Imdat ;
Gueney, Ercihan .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2007, 136 (02) :287-290
[9]  
CANDELA FC, 1990, ARCH OTOLARYNGOL, V116, P432
[10]   Efficacy of routine bilateral neck dissection in the management of supraglottic cancer [J].
Chiu, RJ ;
Myers, EN ;
Johnson, JT .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 131 (04) :485-488